Methods and systems for separating, detecting, and/or quantifying sample enantiomers using differential mobility spectrometry (DMS) are provided herein. In accordance with various aspects of the applicant's teachings, the methods and systems can provide for the separation of racemic or non-racemic mixtures of sample enantiomers that may be difficult to separate with conventional techniques, such as mass spectrometry (MS), by reacting the sample enantiomers with an enantiomerically-pure compound to form diastereomers separable by DMS.

Methods and systems for separating, detecting, and/or quantifying sample enantiomers using differential mobility spectrometry (DMS) are provided herein. In accordance with various aspects of the applicant's teachings, the methods and systems can provide for the separation of racemic or non-racemic mixtures of sample enantiomers that may be difficult to separate with conventional techniques, such as mass spectrometry (MS), by reacting the sample enantiomers with an enantiomerically-pure compound to form diastereomers separable by DMS.

The disclosure provides methods, formulations, and apparatus for making and using cannabinoid formulations.

Techniques and systems for separating components of a mixture of compressed gases each having different boiling points are described. One example system includes multiple recovery stages that each recover one of the gases by condensing it into liquid form. The recovery stages are chained together, such that each stage recovers a gas having a boiling point that is higher than those of the gases to be recovered in downstream stages. Each stage typically includes a warming element that is fluidly coupled to a condenser element that provides a surface cooled to a temperature low enough to condense one of the gases, but high enough such that the remaining gases remain in gaseous form. The system may include an initial evaporator stage that heats a liquid solution of phytochemical extracts and multiple solvents, thereby recovering the extracts and producing the mixture of gaseous solvents.

Techniques and systems for separating components of a mixture of compressed gases each having different boiling points are described. One example system includes multiple recovery stages that each recover one of the gases by condensing it into liquid form. The recovery stages are chained together, such that each stage recovers a gas having a boiling point that is higher than those of the gases to be recovered in downstream stages. Each stage typically includes a warming element that is fluidly coupled to a condenser element that provides a surface cooled to a temperature low enough to condense one of the gases, but high enough such that the remaining gases remain in gaseous form. The system may include an initial evaporator stage that heats a liquid solution of phytochemical extracts and multiple solvents, thereby recovering the extracts and producing the mixture of gaseous solvents.

Lanthanide compounds for vapor deposition having ≤50.0 ppm, ≤30.0 ppm, or ≤10.0 ppm of all halide impurity combined is provided. The purification systems and methods are also provided.

Fulvic acid prepared according to the inventions disclosed herein is suitable for human topical or oral application for hemostatic effect, for cosmetic effect, for antioxidative effect, for antiviral effect, or for elevation of immune system.

Fulvic acid prepared according to the inventions disclosed herein is suitable for human topical or oral application for hemostatic effect, for cosmetic effect, for antioxidative effect, for antiviral effect, or for elevation of immune system.

A process for the preparation of bio-based malonic acid and crystalline calcium malonate is provided. The calcium malonate is highly pure and provides a source of malonic acid made from a renewable carbon source rather than existing processes which rely on the use of petroleum-based products. The calcium malonate provides an improved source of malonic acid, which is important to many industrial processes.

A process is incorporated herein for the synthesis of bio-1,2-alkanediols, comprising: providing a bio-alkene having a carbon chain of about 5 to about 20 carbon atoms and a bio-1-alkene regioselectivity of at least about 80%, at least about 92% and/or at least about 95%; and converting the bio-alkene to a bio-1,2-alkanediol having a carbon chain length of about 5 to about 20 carbon atoms. Methods for treating catalysts which may be incorporated in the process for the synthesis of bio-1,2-alkanediols are also included herein. Such bio-1,2-alkanediols are used in compositions and products alone as antimicrobial materials, or with existing bio-compounds and/or antimicrobials, preservatives, alternative preservation systems and/or hurdle technology components. The bio-1,2-alkanediols incorporate a natural and bio-based pathway for antimicrobial effects in various compositions such as cosmetic, pharmaceutical, industrial and household products.